Sitagliptin manufature CAS NO.486460-32-6

Product Name: sitagliptin            

Synonyms:Janumet;Sitagliptin;Unii-qfp0p1dv7z;          

CAS#:486460-32-6            

Molecular formula: c16h15f6n5o            

Molecular weight: 407.32            

Content: > 99.0%            

EE: >99.0%            

Appearance: white crystalline powder

Brief introduction：Sitagliptin (English: sitagliptin) is an oral hypoglycemic drug (antidiabetic drug), belonging to dipeptidyl peptidase-4 (DPP-4) inhibitor, developed and sold by Merck. Sitagliptin can be used alone or in combination with other oral hypoglycemic agents (such as metformin or thiazolidinedione) to treat type 2 diabetes. The advantage of sitagliptin is that there are fewer side effects in controlling blood glucose levels (such as lower risk of hypoglycemia and weight gain). Although its safety is its advantage, its effect can not be guaranteed, so it is generally recommended to be combined with other drugs such as metformin

Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization.  Starting from the advantages of combining technology research and stable production, we cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.

It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.